- Home
- HLMN vs ZLAB Comparison
HLMN vs ZLAB Comparison
Compare HLMN & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HLMN | ZLAB |
|---|---|---|
| Founded | 1964 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | HLMN | ZLAB |
|---|---|---|
| Price | $8.20 | $19.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | $11.60 | ★ $49.44 |
| AVG Volume (30 Days) | ★ 1.9M | 588.5K |
| Earning Date | 05-22-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 122.22 | 38.46 |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $1,552,224,000.00 | $460,156,000.00 |
| Revenue This Year | $7.65 | $14.46 |
| Revenue Next Year | $4.79 | $29.47 |
| P/E Ratio | $40.68 | ★ N/A |
| Revenue Growth | 5.41 | ★ 15.33 |
| 52 Week Low | $6.63 | $15.96 |
| 52 Week High | $10.85 | $44.34 |
Technical Indicators
Market Signals| Indicator | HLMN | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 35.65 | 52.03 |
| Support Level | $7.95 | $16.65 |
| Resistance Level | $10.31 | $19.70 |
| Average True Range (ATR) | 0.30 | 0.73 |
| MACD | -0.06 | -0.05 |
| Stochastic Oscillator | 23.57 | 66.35 |
Price Performance
Historical ComparisonAbout HLMN Hillman Solutions Corp.
Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the company are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the U.S., Canada and Mexico.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.